Nocardia infections in Italy: from a local to a national view

New Microbiol. 2023 Feb;46(1):68-74.

Abstract

In this paper, we have described cases of nocardiosis that occurred in our hospital and examined the literature on other nocardiosis cases recorded in Italy. We have collected the clinical details of our recent cases and described them in full. Regarding the older cases in our hospital and the Italian cases present in the literature, we noted the clinical data, the Nocardia species involved, and the antimicrobial susceptibility reported. The survey was carried out on PubMed. The first of our cases is an elderly woman with compromised health who had a lung and bloodstream infection. A second case is a middle-aged man who developed an infection in the thigh. A third patient is a middle-aged man on immunosuppressive therapy who developed a cerebral abscess. Our review shows that patients are usually immunocompromised, with an average age of 60 years, and more frequently males. The most affected organs are the lungs and the brain, and the most reported species is Nocardia farcinica. Antimicrobial susceptibility tests show good efficacy of linezolid, cotrimoxazole and amikacin. We conclude that, if a Nocardia infection is suspected, the most likely species to be considered in Italy is N. farcinica. In addition, if empirical therapy is needed, we suggest relying on linezolid, cotrimoxazole or amikacin.

Keywords: Antimicrobial susceptibility; Case report; Cases review; Italy; Nocardiosis.

Publication types

  • Review

MeSH terms

  • Aged
  • Amikacin
  • Anti-Infective Agents*
  • Female
  • Humans
  • Italy / epidemiology
  • Linezolid
  • Male
  • Middle Aged
  • Nocardia Infections* / drug therapy
  • Trimethoprim, Sulfamethoxazole Drug Combination

Substances

  • Amikacin
  • Linezolid
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Anti-Infective Agents